This article explains new research showing that getting blood sugar back to normal from prediabetes can cut the long-term risk of heart problems, describes the studies and their limits, and offers practical questions patients should ask clinicians about testing, risk and treatment options.
New research links turning prediabetes into normal blood sugar with far lower heart risk down the road. Scientists compared long-term outcomes from two big cohorts and found people who achieved remission had markedly fewer major heart events and lower death rates than those who stayed in the prediabetic range. That pattern held across diverse populations and decades of follow-up.
Researchers dug into a 20-year American study and a 30-year Chinese study to see what happened after efforts to lower blood sugar. Participants were coached on diet, exercise and weight loss, and some were treated with medication when appropriate. The teams split people into those who returned to normal glucose levels and those who did not, then tracked heart-related hospitalizations and deaths.
The outcomes were striking: the remission group showed a roughly 58 percent lower risk of dying from heart disease or being hospitalized for heart failure. That group also saw fewer other major cardiac events and an overall drop in mortality. The protective effect appeared to last for decades after the lifestyle programs ended, suggesting a durable benefit from early intervention.
“Reaching prediabetes remission is linked to a decades-long benefit, halving the risk of cardiovascular death or hospitalization for heart failure in diverse populations,” the researchers commented in the publication of the study. “Targeting remission might represent a new approach to cardiovascular prevention.” Those words capture a simple idea: act early, and the benefits can be long-lasting.
Study co-author Dr. Andreas Birkenfeld emphasized that remission is not just about avoiding diabetes; it may also lower heart attack risk. He said the findings point to a “meaningful reduction in… heart attack risk, cardiac death and heart failure.” That links metabolic control with concrete cardiovascular outcomes, not just lab numbers on a chart.
Still, the analysis has limits worth noting. The trials were not originally designed to measure cardiovascular events, so the results show association rather than definitive proof of cause. Differences in populations, unmeasured lifestyle factors and the lack of randomized heart outcome measures could have influenced the results, the researchers warned.
Practical advice from the study is straightforward: people with prediabetes should get clear, personalized guidance from their doctors. Ask questions like “What is my current status? What is my personal cardiovascular risk? What is my target blood glucose level?” and push for appropriate testing of blood sugar and major risk markers. Regular checks of blood pressure, cholesterol, kidney function and conditions like sleep apnea can reveal risks that interact with glucose control.
Where lifestyle change falls short, medication can be considered for selected patients. Birkenfeld suggested bringing up the trade-offs with your clinician by asking, “If lifestyle changes aren’t enough or my risk is high, would medication be appropriate for me — and what are the benefits and downsides?” That frames the choice as a targeted intervention rather than a one-size-fits-all prescription.
For context, prediabetes is common and often hidden: about 98 million American adults—more than one in three—have the condition, and roughly eight in 10 of them don’t know it. That makes routine screening and clear communication from clinicians essential if the goal is to prevent both diabetes and downstream heart disease. Early detection opens a window where relatively modest changes can have big payoffs.
In practice, lowering blood sugar through weight loss, improved diet and consistent physical activity remains the cornerstone of remission efforts. For many people, those steps reduce glucose enough to return to a normal range and, according to this research, cut their long-term cardiac risk. The message is simple and actionable: treat prediabetes as a chance to prevent more serious problems later.
